Screening/Prevention
Being Overweight Associated with Increased Risk of Several Cancers
(02/19/2008)
Excess bodyweight increases the risk of developing several types of cancer, according to results recently published in The Lancet.
Sunlight Linked to Lower Endometrial Cancer Rates
(12/10/2007)
According to the results of a study published in Preventive Medicine, countries with higher levels of sunlight tend to have lower rates of endometrial cancer; this may be due the link between sunlight and vitamin D.
Higher Levels of Immune Cells Linked to Risk of Cancer in Postmenopausal Women
(10/03/2007)
According to results recently published in the Archives of Internal Medicine, postmenopausal women with higher levels of white blood cells (a type of immune cell) have a higher risk of developing specific types of cancer and dying from cancer.
Additional Evidence that Estrogen Alone Increases the Risk of Endometrial Cancer
(11/09/2006)
A study published in the American Journal of Epidemiology provides additional evidence that postmenopausal hormone therapy consisting of estrogen alone increases the risk of endometrial (uterine) cancer in women who have not had a hysterectomy. Consistent with most previous studies, use of combined estrogen plus progestin did not increase the risk of endometrial cancer.
Study Explores Risk of Breast, Uterine, and Ovarian Cancer in Women with AIDS
(09/29/2006)
According to the results of a study published in the British Journal of Cancer, women with AIDS have a lower risk of endometrial (uterine) cancer than women in the general population; risk of breast cancer was lower among women with AIDS in the pre-HAART (highly active antiretroviral therapy) era, but is now similar to the risk among women in the general population.
More...
Stages I-III
Differences in IMRT Radiation Doses May Complicate Study Results in Gynecological Cancers
(03/31/2008)
Differences between the prescribed dose of radiation in intensity modulated radiation therapy (IMRT) and the dose that’s actually delivered may make comparison studies in gynecological cancers difficult to interpret. These findings were reported in the Journal of the National Cancer Institute.
Risk Factors Identified for Uterine Sarcoma Survival
(02/20/2008)
Survival for patients diagnosed with uterine leiomyosarcomas may be influenced by several factors. These findings were recently published in the journal Cancer.
Better Quality of Life with Vaginal Brachytherapy for Endometrial Cancer
(09/27/2007)
Among women who received post-surgery radiation therapy for endometrial cancer, vaginal brachytherapy (a type of internal radiation therapy) resulted in better quality of life than external beam radiation therapy. These results were presented at the European Cancer Conference (ECCO 14).
Psychosocial Needs of Survivors of Gynecologic Cancers Must Be Addressed
(01/29/2007)
According to an article recently published in Gynecologic Oncology, nearly one-third of survivors of a gynecologic cancer suffer from anxiety or post-traumatic stress disorder symptoms.
In-hospital Deaths Lower for High-volume Surgeons for Uterine Cancer
(12/06/2006)
According to an article recently published in Gynecologic Oncology, short term outcomes of surgery for uterine cancer are better if the surgery is performed by surgeons who perform a high volume of these surgeries.
More...
Stage IV
Risk Factors Identified for Uterine Sarcoma Survival
(02/20/2008)
Survival for patients diagnosed with uterine leiomyosarcomas may be influenced by several factors. These findings were recently published in the journal Cancer.
Psychosocial Needs of Survivors of Gynecologic Cancers Must Be Addressed
(01/29/2007)
According to an article recently published in Gynecologic Oncology, nearly one-third of survivors of a gynecologic cancer suffer from anxiety or post-traumatic stress disorder symptoms.
More Extensive Lymph Node Removal Improves Survival in Intermediate- and High-risk Endometrial Cancer Patients
(09/25/2006)
According to the results of a study published in the journal Cancer, removal of a larger number of lymph nodes improves survival among women with intermediate or high-risk endometrial cancer (Stage IB, Grade 3; Stage IC-IV, all grades).
Chemotherapy Superior to Radiation in the treatment of Carcinosarcoma of the Uterus
(06/06/2006)
Chemotherapy has been shown to improve survival compared to whole abdominal radiation in the treatment of women with a rare form of uterine cancer—carcinosarcoma of the uterus—who have undergone surgery to remove most of their disease. These results were presented at the 42nd annual meeting of the American Society of Clinical Oncology (ASCO) held in Atlanta, Georgia, June 2-6, 2006.
Removal of Lymph Nodes During Surgery Improves Survival of Patients with Endometrial Uterine Cancer
(06/06/2006)
The removal of lymph nodes during surgery appears to improve cancer-free survival among some patients with endometrial uterine cancer. These findings were presented at the 42nd annual meeting of the American Society of Clinical Oncology (ASCO) held in Atlanta, Georgia, June 2-6, 2006.
More...
Recurrent
Neulasta® on First Day of Chemotherapy May Be More Convenient for Gynecologic Cancers
(03/17/2008)
The administration of the blood cell growth factor Neulasta® (pegfilgrastim) on the first day of chemotherapy among women with gynecologic cancers may be as effective as and more convenient than second-day administration. These results were recently reported at the 2008 annual Society of Gynecologic Oncologists meeting.
Stress and Depression Frequent Among Women Treated for Gynecological Cancers
(02/22/2005)
According to the results of a study recently published in Gynecologic Oncology, women with gynecologic cancer often experience emotional stress and depression after losing their fertility from cancer treatment.
Oral Etoposide Shows Modest Activity, with Minimal Side Effects, against Recurrent Endometrial Cancer
(02/26/2002)
Chemotherapy with oral etoposide may benefit women who have recurrent or metastatic endometrial cancer, and may hold promise for improved effectiveness when used in combination with other drugs, according to a recent report by the Southwest Oncology Group.
Brachytherapy after Surgery Appears to Help Prevent Recurrences in Persons with Stage I Endometrial Cancer
(02/26/2002)
The use of brachytherapy (radioactive implants) after surgery for stage I endometrial cancer appears to help prevent cancer recurrences in the area of the uterus, according to a new study by Arizona researchers. This finding offers hope for an effective alternative to external-beam radiation therapy for women with this disease.
Intensive Chemotherapy Is Effective for Women Previously Treated for Gestational Trophoblastic Tumors
(02/26/2002)
Gestational trophoblastic tumors are rare but highly curable cancers that develop from the products in the uterus (or womb) after conception of the sperm and egg. Some women with gestational trophoblastic tumors (GTT) can be cured with surgery, while others need chemotherapy. Most women who need chemotherapy (95 to 97%) are cured; however, a few may have resistant or recurrent (returning) disease and need additional treatment. Now, researchers in England report that an intensive chemotherapy regimen of etoposide, cisplatin/etoposide, methotrexate, and actinomycin D is effective for women with GTT for whom previous chemotherapy has failed.
More...